glp 1 bipolar Glp-1 meds and bipolar: any differences noticed? Insights into a possible role

Globally, an estimated 19 million people are users of cocaine (United Nations Publication, 2020), and about five million people suffer from cocaine use disorder (CUD) (Peacock et al., 2018)

Saxagliptin was the second one to be approved in 2009 and the others followed thereafter

Benoit SC, Clegg DJ, Seeley RJ, Woods SC

Merchenthaler, I., Lane, M

Advances in antibody engineering have expanded their utility beyond single-target binding to include bispecific antibodies and engineered proteins with increased binding specificity and pharmacokinetic profiles

Olympia is a member of the Outsourcing Facilities Association (OFA) trade group that sued the FDA twice over the removal of tirzepatide and then semaglutide (Ozempics active ingredient) from its shortage list